BackgroundCheck.run
Search For

Meghan Elizabeth Johnston, 35Franklin, MA

Known as:
Meghan E Johnston Meghan J Frost
Related to:
Robert Mcintyre

Meghan Johnston Phones & Addresses

Franklin, MA   

808 E 3Rd St, South Boston, MA 02127   

Boston, MA   

Allen, TX   

Providence, RI   

237 Sunnybrook Farm Rd, Narragansett, RI 02882    401-7888237   

McKinney, TX   

Get Report
Control this profile

Mentions for Meghan Elizabeth Johnston

Career records & work history

Medicine Doctors

Meghan E. Johnston

Specialties:
Internal Medicine
Work:
Spinnelli Internal Medicine
925 Highland Blvd STE 1100, Bozeman, MT 59715
406-5565533 (phone) 406-4145530 (fax)
Languages:
English
Description:
Dr. Johnston works in Bozeman, MT and specializes in Internal Medicine. Dr. Johnston is affiliated with Bozeman Deaconess Health Services.

Meghan Johnston resumes & CV records

Resumes

Meghan Johnston Photo 42

Search Director At Management Search Of Rhode Island. Contact Me At- [email protected] Or 401 808 8629

Location:
Providence, Rhode Island Area
Industry:
Staffing and Recruiting
Meghan Johnston Photo 43

Meghan Johnston

Location:
United States

Publications & IP owners

Us Patents

Pharmaceutical Composition And Administrations Thereof

US Patent:
2013022, Aug 29, 2013
Filed:
Feb 27, 2013
Appl. No.:
13/779654
Inventors:
VERTEX PHARMACEUTICALS INCORPORATED - , US
SHAHLA JAMZAD - BELMONT MA, US
MAJED FAWAZ - FOXBORO MA, US
LAURA DAS - CHARLESTOWN MA, US
CHONG-HUI GU - WABAN MA, US
PATRICIA NELL HURTER - HARVARD MA, US
MEGHNA JAI ISRANI - BOSTON MA, US
MEGHAN M. JOHNSTON - WAKEFIELD MA, US
DRAGUTIN KNEZIC - WATERTOWN MA, US
ANDREW G. KUZMISSION - SHREWSBURY MA, US
HONGREN WANG - LEXINGTON MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - CAMBRIDGE MA
International Classification:
A61K 31/47
US Classification:
424464, 514312
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N—[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Pharmaceutical Composition And Administrations Thereof

US Patent:
2022024, Aug 4, 2022
Filed:
Sep 15, 2021
Appl. No.:
17/475622
Inventors:
- Boston MA, US
Shahla JAMZAD - Belmont MA, US
Majed FAWAZ - Foxboro MA, US
Laura DAS - Charlestown MA, US
Chong-Hui GU - Waban MA, US
Patricia Nell HURTER - Harvard MA, US
Meghna Jai ISRANI - Boston MA, US
Meghan M. JOHNSTON - Wakefield MA, US
Dragutin KNEZIC - Watertown MA, US
Andrew G. KUZMISSION - Shrewsbury MA, US
HongRen WANG - Lexington MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Boston MA
International Classification:
A61K 9/20
A61K 31/47
A61K 9/16
A61K 9/48
C07D 215/56
A61K 9/14
A61K 47/02
A61K 47/12
A61K 47/20
A61K 47/26
A61K 47/38
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Pharmaceutical Composition And Administrations Thereof

US Patent:
2019027, Sep 12, 2019
Filed:
Mar 12, 2019
Appl. No.:
16/299675
Inventors:
- Boston MA, US
Shahla JAMZAD - Belmont MA, US
Majed FAWAZ - Foxboro MA, US
Laura DAS - Charlestown MA, US
Chong-Hui GU - Waban MA, US
Patricia Nell HURTER - Harvard MA, US
Meghna Jai ISRANI - Boston MA, US
Meghan M. JOHNSTON - Wakefield MA, US
Dragutin KNEZIC - Watertown MA, US
Andrew G. KUZMISSION - Shrewsbury MA, US
HongRen WANG - Lexington MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Boston MA
International Classification:
A61K 9/20
A61K 31/47
A61K 9/16
A61K 9/14
A61K 47/02
A61K 47/38
A61K 47/20
A61K 47/26
A61K 9/48
C07D 215/56
A61K 47/12
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Pharmaceutical Composition And Administrations Thereof

US Patent:
2017010, Apr 13, 2017
Filed:
Jun 13, 2016
Appl. No.:
15/181114
Inventors:
- Boston MA, US
Shahla JAMZAD - Belmont MA, US
Majed FAWAZ - Foxboro MA, US
Laura DAS - Charlestown MA, US
Chong-Hui GU - Waban MA, US
Patricia Nell HURTER - Harvard MA, US
Meghna Jai ISRANI - Boston MA, US
Meghan M. JOHNSTON - Wakefield MA, US
Dragutin KNEZIC - Watertown MA, US
Andrew G. KUZMISSION - Shrewsburg MA, US
HongRen WANG - Lexington MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Boston MA
International Classification:
A61K 9/20
A61K 31/47
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Pharmaceutical Composition And Administrations Thereof

US Patent:
2015024, Sep 3, 2015
Filed:
May 19, 2015
Appl. No.:
14/715682
Inventors:
- Boston MA, US
Shahla Jamzad - Belmont MA, US
Majed Fawaz - Foxboro MA, US
Laura Das - Charlestown MA, US
Chong-Hui Gu - Waban MA, US
Patricia Nell Hurter - Harvard MA, US
Meghan M. Johnston - Wakefield MA, US
Dragutin Knezic - Watertown MA, US
Andrew G. Kuzmission - Shrewsburg MA, US
HongRen Wang - Lexington MA, US
International Classification:
A61K 31/47
A61K 47/38
A61K 9/20
A61K 47/12
A61K 47/20
A61K 47/26
A61K 47/02
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Pharmaceutical Composition And Administrations Thereof

US Patent:
2015002, Jan 22, 2015
Filed:
Oct 9, 2014
Appl. No.:
14/510507
Inventors:
- Boston MA, US
Shahla Jamzad - Belmont MA, US
Majed Fawaz - Foxboro MA, US
Laura Das - Charlestown MA, US
Chong-Hui Gu - Waban MA, US
Patricia Nell Hurter - Harvard MA, US
Meghna Jai Israni - Boston MA, US
Meghan M. Johnston - Wakefield MA, US
Dragutin Knezic - Watertown MA, US
Andrew G. Kuzmission - Shrewsburg MA, US
HongRen Wang - Lexington MA, US
International Classification:
A61K 31/47
A61K 47/12
A61K 47/38
A61K 9/16
A61K 47/26
A61K 9/20
A61K 9/14
A61K 47/02
A61K 47/20
US Classification:
424464, 514312
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Pharmaceutical Composition And Administrations Thereof

US Patent:
2014025, Sep 11, 2014
Filed:
May 23, 2014
Appl. No.:
14/286856
Inventors:
- Boston MA, US
Shahla Jamzad - Belmont MA, US
Majed Fawaz - Foxboro MA, US
Laura Das - Charlestown MA, US
Chong-Hui Gu - Waban MA, US
Patricia Nell Hurter - Harvard MA, US
Meghna Jai Israni - Boston MA, US
Meghan M. Johnston - Wakefield MA, US
Dragutin Knezic - Watertown MA, US
Andrew G. Kuzmission - Shrewsburg MA, US
HongRen Wang - Lexington MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Boston MA
International Classification:
C07D 215/56
A61K 9/20
A61K 9/16
US Classification:
424464, 514312
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Possible Relatives

Cynthia L Johnston  David C Johnston  Dawn M Johnston  Dean Johnston  Deanna V Johnston  Dale Johnston  Dallas R Johnston  Meghan A Johnson  Meghan H White  Meghan D Jolly 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.